Patient satisfaction and quality of life after MammoSite breast brachytherapy - 22/08/11
, Jennifer L. Harper, M.D. b, Carla E. Taylor b, Joseph M. Jenrette, M.D. b
Corresponding author: Tel.: +1-770-836-9824; fax: +1-770-832-9850Abstract |
Purpose |
To perform a satisfaction/quality-of-life (QOL) survey of patients undergoing MammoSite brachytherapy (MBT; Hologic, Inc, Marlborough, MA).
Methods |
We asked patients 15 questions regarding treatment decision-making, and experience on-therapy/post-treatment.
Results |
A total of 52 patients responded (median follow-up 30 months). Regarding decision-making, 5.8% viewed the avoidance of mastectomy as “not important.” If MBT were not available, 55.8% would opt for whole-breast radiotherapy (WBRT) without difficulty, 28.8% would have significant travel/financial difficulty, and 15.4% would refuse radiotherapy/opt for mastectomy. Regarding choice factors, patients selected “focused therapy” (44.2%), “convenience” (36.5%), and “cutting edge” (17.3%). A total of 61.5% patients were not concerned about a second surgical procedure; 90.4% were not/somewhat concerned about infection. During treatment, 73.1% reported no pain/discomfort with catheter, 73.1% no wound difficulty, 51.0% no pain during removal, and 71.2% no pain post-treatment. A total of 98.1% of patients rated the experience good/excellent, 90.4% reported no/minor side effects, 92.3% rated cosmesis good/excellent, 98.1% were very/extremely likely to choose MBT again, and 100% would recommend MBT.
Conclusions |
QOL is high during/after MBT. More data are needed from ongoing trials to compare with WBRT.
Le texte complet de cet article est disponible en PDF.Keywords : Breast cancer, Brachytherapy, Quality of life, MammoSite, Patient satisfaction
| Post-acceptance of this manuscript, A.E.D. accepted an invitation to the speakers' bureau of Hologic, Inc, manufacturer of the MammoSite device. |
Vol 196 - N° 4
P. 545-548 - octobre 2008 Retour au numéro
Article précédent
- Sclerotherapy for the treatment of postmastectomy seroma
- Alyssa D. Throckmorton, Johanna Askegard-Giesmann, Tanya L. Hoskin, Haraldur Bjarnason, John H. Donohue, Judy C. Boughey, Amy C. Degnim
- Mucinous breast carcinoma: a large contemporary series
- Christina R. Barkley, Jennifer A. Ligibel, Julia S. Wong, Stuart Lipsitz, Barbara L. Smith, Mehra Golshan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?